I read an online article today from Benzinga, a financial media company that empowers its readers with daily actionable market analysis and commentary.  It reported on a new ADHD drug that the FDA had just approved, called Cotempla XR-OTD, a methylphenidate extended release orally-disintegrating tablet for treating ADHD in kids aged 6-17.  According to BMO...Read More

A new study of Scottish children published in the JAMA Pediatrics this week, suggests that the 1.0% of subjects (N= 7413) that were being medicated for attention deficit hyperactivity disorder had poorer outcomes on a wide range of measures compared with others in the study (N=766,244). The outcomes included: poor academic attainment, unauthorized absence from...Read More

I’ve been concerned about the lack of input that children and adolescents diagnosed with ADHD have relating to their diagnosis and treatment.  Now a new study in the May 2017 issue of the Community Mental Health Journal reports that children with a diagnosis of ADHD want to talk with their doctors about their diagnosis and the...Read More

A study in The Journal of Child Psychology and Psychiatry last month reported that”extended use of medication [for ADHD] was associated with suppression of adult height but not with reduction of symptom severity.” So basically, it stunts growth and it isn’t effective. So why isn’t there a bigger hue and cry about this? There are...Read More

A new study published in the journal Lancet Psychiatry revealed that certain subcortical structures in the brains of individuals diagnosed with ADHD are smaller in volume than typically developing matched controls (the median age of the 1713 participants diagnosed with ADHD was 14).  The specific structures where differences were found included the nucleus accumbens, the...Read More